Le Lézard

Vektor Medical to Showcase VITAL-EP Registry's Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5?8 in Boston, where new clinical data ...

Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field ...
Le Lézard

Pulse Biosciences Presents Late-Breaking Data from nPulsetm Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

Pulse Biosciences, Inc. , developer of the novel nPulsetm technology using proprietary Nanosecond Pulsed Field Ablationtm ...